title: Ultrastructural changes in prostate cells during hormone-induced canine prostatic hyperplasia.
abstract: Benign prostatic hyperplasia is a prevalent disease that has received relatively little attention in spite of its morbidity and remarkable social impact. There are few animal models of prostatic hyperplasia. The dog is the only species, along with humans, in which prostatic hyperplasia develops spontaneously and almost universally with age. The aim of the present study has been to compare the ultrastructural findings in a model of experimentally induced canine prostatic hyperplasia with those of the spontaneously developed changes in untreated dogs. An experimental group of 5 male beagle dogs were castrated and treated with combined steroids (3 weekly doses for over 30 weeks). Prostate samples were surgically obtained every 42 days (experimental stages 0 through 6). The control group consisted of 3 noncastrated dogs that were treated with vehicle and in which samples were taken only at stages 0, 1, 4, and 6. Changes in the control groups were similar but of lower intensity compared to those of the experimental groups. In luminal cells, crowding with papillary projections, prominent, branching microvilli, and abundant, often compartmentalized granules were observed. The most striking change was the previously unreported finding of caveolae in basal cells. They were mostly located in the basal aspect of basal cells and were more prominent in the experimental group and in advanced stages of treatment. These ultrastructural findings have not been previously reported in canine or human prostatic hyperplasia and merit further research. The model of experimentally induced canine prostatic hyperplasia provides an adequate setting for the understanding of this disease.
authors.affiliation: Departament de Medicina i Cirurgia Animals, Facultat de Veterinaria, Autonomous University of Barcelona, Barcelona, Spain.
authors.forename: Fanny
authors.initials: F
authors.lastname: Gallardo-Arrieta
authors.forename: Teresa
authors.initials: T
authors.lastname: Mogas
authors.forename: Luís
authors.initials: L
authors.lastname: Magán
authors.forename: María A
authors.initials: MA
authors.lastname: García
authors.forename: Félix
authors.initials: F
authors.lastname: García
authors.forename: Miguel
authors.initials: M
authors.lastname: Abal
authors.forename: Joan
authors.initials: J
authors.lastname: Morote
authors.forename: Sergi
authors.initials: S
authors.lastname: Serrano
authors.forename: Jaume
authors.initials: J
authors.lastname: Reventós
authors.forename: Josep
authors.initials: J
authors.lastname: Lioreta
mesh_terms: D015113:Androstane-3,17-diol / Q000633:toxicity; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D004958:Estradiol / Q000633:toxicity; D008297:Male; D046529:Microscopy, Electron, Transmission; D011467:Prostate / Q000187:drug effects / Q000648:ultrastructure*; D011470:Prostatic Hyperplasia / Q000139:chemically induced / Q000473:pathology*
chemical_list: D015113:Androstane-3,17-diol; D004958:Estradiol